Skullcap (Scutellaria spp.): A Comprehensive Reference
1. Identity: Botanical Names, Natural Source, and Common Forms
1.1 Taxonomy and Species
Scutellaria is a genus of flowering plants in the mint family, Lamiaceae, collectively known as skullcaps. The generic name derives from the Latin scutella, meaning "a small dish, tray or platter," referring to the shape of the calyx. Estimates of the number of species in the genus range from around 300 to about 350 or 360 to 470. Of these, two species dominate modern herbal and medicinal use:
- American skullcap (Scutellaria lateriflora L.) — Commonly known as "blue skullcap," "mad dog skullcap," "American skullcap," and "side-flowering skullcap," it is a hardy perennial herb of the mint family, Lamiaceae, native to North America. It has an upright habit, growing 60–80 cm in maximum height, and is a wetland-loving species that grows near marshes, meadows, and other wet habitats.
- Chinese or Baikal skullcap (Scutellaria baicalensis Georgi) — Scutellaria baicalensis, with the common name Baikal skullcap or Chinese skullcap, is a species of flowering plant in the family Lamiaceae, native to China, Korea, Mongolia, and Russia in the Russian Far East and Siberia. It is one of the 50 fundamental herbs used in traditional Chinese medicine, where it has the name huángqín (黄芩).
A third species, Scutellaria barbata D. Don (barbat skullcap), is also used medicinally in East Asia, particularly in Traditional Chinese Medicine. The genus Scutellaria in the Lamiaceae (mint) family has approximately 350 species, some of which are medicinally active.
Scutellaria lateriflora is also known as Virginian Skullcap and Blue Skullcap. Scutellaria galericulata is also known as Marsh Skullcap. Scutellaria baicalensis Georgi is also known as baical skullcap, huangcen, huang lien, huangqin, hwanggum, hwang-keum, Koganebana, skullcap, senohgon, whang-geum, whangegum, wogon, and golden root.
1.2 Morphology and Habitat
Scutellaria lateriflora is a perennial herb native to North America and Canada, favouring woods, thickets and damp areas such as riverbanks and marshes. It has slender, toothed leaves and pale blue, or occasionally white or pink flowers produced on one side of the stem. Scutellaria baicalensis, belonging to the Lamiaceae botanical family, is native to East Asia; it is a herb growing to 0.3 m on sunny grassy slopes, waste and cultivated areas.
1.3 Plant Parts Used and Common Preparations
The above-ground parts, principally the leaves and flowers, are used medicinally for S. lateriflora, while the root of Scutellaria baicalensis Georgi is the part used in traditional Chinese medicine. Farmers and collectors harvest the plants while they are flowering — the peak of their herbal power — then cut and dry the leaves and stems to use as herbal medicine.
Skullcap is available in multiple commercial forms:
- Skullcap is sold in capsules, powders, and liquid extracts. Dried parts of the plant, such as its leaves, are likewise used to brew tea.
- Capsules typically contain powdered skullcap herb (either Scutellaria lateriflora or Scutellaria baicalensis), with dosages often ranging between 350 mg and 1000 mg.
- Tinctures offer a concentrated dose of skullcap extract in liquid form, often alcohol-based, and are taken by drops in water or directly under the tongue.
- Most often, S. lateriflora is prescribed as a tincture, although teas and tablets are also commercially available, with wide variability depending on the manufacturer and species of Scutellaria used.
1.4 Identity and Adulteration Issues
Misidentification may occur with small-scale herb farming and the possibility of those with an untrained eye gathering skullcap herb from the wild. Accidental substitution of S. lateriflora in the market may occur and perpetuate when the wrong species is cultivated by even large-scale commercial growers. Some skullcaps labelled as S. lateriflora in garden nurseries can in fact be S. altissima, which has similar flavonoid content, but has not been widely explored for its medicinal benefit.
2. Traditional and Historical Use
2.1 Native American and Early North American Traditions
Scutellaria lateriflora L., commonly called American skullcap, is a North American native herb which is traditionally used as a nerve tonic. Indigenous peoples including Cherokee, Iroquois, Ojibwe, and other tribes traditionally used skullcap as part of their ethnobotanical knowledge systems. European settlers and folk herbalists learned how to use skullcap from Cherokees and Native American tribes, who had traditionally consumed it as a tea to soothe the nerves, to promote women's health, and it was sometimes used in ceremony.
Skullcap was used by Native American tribes to relieve breast pain, promote menstruation and in childbirth to help expel the placenta. In addition to its reputation as an effective remedy against rabies, skullcap was used by Native Americans to promote menstruation. A root extraction was often taken after childbirth to help heal the reproductive system.
In 1773, Scutellaria lateriflora became a common treatment in North America for the hysteria and hydrophobia caused by rabies. Today it is still a popular medicinal herb. Its folk name "mad-dog skullcap" arose from this historical application.
2.2 Eclectic Medicine (19th Century America)
Eclectic physicians — a group of 19th-century American practitioners who championed botanical medicine — considered it one of their most valued tools for treating an overstimulated nervous system. Early American herbalists documented skullcap in their materia medica, with the plant appearing in various botanical texts and pharmacopeias from the eighteenth and nineteenth centuries. Herbal physicians then brought it back to Great Britain in the 19th century, introducing more people to its relaxing benefits.
2.3 Traditional Chinese Medicine (S. baicalensis)
Scutellaria baicalensis is a very commonly prescribed herb in traditional Chinese medicine and is also known as Baikal skullcap or Huang-qin. A common drug in traditional Chinese medicine, its root is used as a febrifuge for relieving fever and diminishing inflammation. It is used internally in the treatment of enteritis, dysentery, diarrhea, jaundice, chronic hepatitis, urinary tract infections, hypertension, threatened miscarriage, nosebleed, and hemorrhage from the lungs or bowels.
In contemporary clinical research, Scutellaria baicalensis is frequently employed for the treatment of diseases such as liver damage, acute pulmonary infection, gastrointestinal inflammation, diarrhea in infants, and pregnancy-related vomiting.
3. Key Phytochemical Constituents
3.1 Primary Active Compounds
The main compounds in skullcap are flavonoids. The two species share many key constituents, though their relative concentrations differ. For S. baicalensis:
Several phytochemicals have been isolated from the root; baicalein, baicalin, wogonin, norwogonin, oroxylin A, and β-sitosterol are the major ones. Chinese Skullcap was found to contain a diverse array of phytochemical constituents, including flavonoids, alkaloids, and terpenoids, with baicalin and baicalein being the most prominent bioactive compounds. The plant root contains major active constituents including flavonoids and flavoglycosides such as wogonin, baicalein, baicalin, oroxylin A, scutellarein, and norwogonin.
For S. lateriflora:
The principal phytochemicals are polyphenols in the leaves, stems, and roots, including baicalin, baicalein, wogonin, and oroxylin A. Chemical constituents of Scutellaria lateriflora include flavonoid glycosides (including wogonin, baicalin), scutellarin, volatile oils, lignans, resins, diterpenoids, bitters, tannins, iridoids, phenols, B vitamins, minerals, iron, silica, calcium, potassium and magnesium.
Scutellaria baicalensis contains at least 126 small molecules and 6 polysaccharides. It possesses anti-tumor, anti-viral, anti-microbial, anti-inflammatory, antioxidative, and neuroprotective activities. Chemical compounds responsible for many of these activities are still unknown, though the bioactivities of a few major compounds (baicalin, baicalein, wogonoside, and wogonin) have been extensively studied.
3.2 Profiles of the Principal Flavonoids
- Baicalin — the glycoside form of baicalein; baicalin is the main metabolite of S. baicalensis extract.
- Baicalein — a flavone (5,6,7-trihydroxyflavone) originally extracted from the roots of Scutellaria baicalensis and Scutellaria lateriflora.
- Wogonin — Wogonin (5,7-Dihydroxy-8-methoxyflavone) is a flavonoid-like phytochemical and a major therapeutic compound in Scutellaria baicalensis, demonstrated to have anti-inflammatory, anti-oxidant, and anti-apoptotic effects.
- Oroxylin A — one of several O-methylated flavonoids found in both primary species.
- Scutellarin — a flavone glycoside (scutellarein-7-glucuronide) particularly associated with S. lateriflora.
4. Established Mechanisms of Action
4.1 GABAergic Modulation (Anxiolytic/Sedative)
Two studies found major skullcap flavonoids, including baicalin, baicalein, and wogonin, extracted from S. baicalensis but also found in S. lateriflora, had affinities for the benzodiazepine binding site of GABAA receptors, suggesting anxiolytic properties for these flavonoids. Ligands binding to the benzodiazepine site of the GABAA receptor decrease the likelihood of action potentials by excitatory neurotransmitters such as adrenalin and noradrenalin, implicated in anxiety and stress.
In vitro, aqueous extracts of skullcap induced release of [³H] GABA in rat brain synaptosomes. Inhibition of GABA reuptake in cells explains the in vivo mechanism by which skullcap has an inhibitory effect on neurotransmission.
4.2 Serotonergic Modulation
The discovery of relatively high quantities of serotonin in skullcap may explain the in vitro study, which found that skullcap extracts bind to the serotonin 5-HT7 receptor. The receptor binding affinities of flavonoids present in S. lateriflora, including baicalein, baicalin, wogonin, and scutellarein, to GABAA-BDZ receptor sites in vitro, indicates a possible anxiolytic action for the herb, as does the presence of glutamine and the ability of certain S. lateriflora flavonoids to bind to 5-HT7 receptors in vitro.
4.3 Anti-inflammatory Mechanisms
The flavonoids, particularly baicalin and baicalein, have been identified as the major contributors to antioxidant and anti-inflammatory effects. These properties make Chinese skullcap a promising candidate for treating various inflammatory conditions and oxidative stress-related disorders.
4.4 Cardiovascular Mechanisms
Previous studies have summarized the significant clinical potential of baicalin in the treatment of atherosclerosis (AS), myocardial ischemia–reperfusion injury (MIRI), hypertension, and heart failure through mechanisms including the regulation of lipid metabolism, the reduction of inflammation-induced damage, the inhibition of oxidative stress, the attenuation of apoptosis, and immune modulation.
4.5 Antitumor Mechanisms (Preclinical)
Baicalein, baicalin, and wogonin induce autophagy, cell cycle arrest, and necrosis by PI3K/Akt/mTOR, Hippo, and NF-κB pathways. Baicalin and baicalein also inhibited migration by decreasing adhesion molecule release. The mechanisms of S. baicalensis have been demonstrated mainly via the apoptosis of hepatoma cells induced by mitochondria and cell death receptors, and with inhibition of cell proliferation. In addition, S. baicalensis can also induce autophagy of stem-cell receptors, regulate angiogenesis-related proteins and genes, and regulate the tumor immune microenvironment.
4.6 Synergistic Action
It is likely that the efficacy of S. lateriflora is due to its multiple constituents acting in synergy rather than to the summative activities of the constituent phytochemicals. There is still a need for more research into the pharmacology of extracts from whole aerial parts of the herb and the variability which may arise from the herb sourced from different origins.
5. Scientific Evidence by Area of Use
5.1 Anxiety and Mood
Preclinical (animal and in vitro) evidence:
The phytochemistry and biological activity of Scutellaria lateriflora L. (American skullcap), which has been traditionally used as a sedative and to treat various nervous disorders such as anxiety, was studied. In vivo animal behaviour trials were performed to test anxiolytic effects in rats orally administered S. lateriflora extracts. Significant increases in the number of entries into the center of an "open-field arena," number of unprotected head dips, number of entries and the length of time spent on the open arms of the Elevated Plus-Maze were found.
An in vivo behavioural test measuring the anxiolytic responses in rats administered aqueous extracts of skullcap showed a significant difference between treated and control rats (n=21, p<0.05).
Human clinical evidence:
Scutellaria lateriflora, a traditional herbal remedy for stress and anxiety, was tested on human volunteers for its effects on mood. In a placebo-controlled, double-blind, crossover study, 43 healthy participants were randomised to a sequence of three times daily S. lateriflora (350 mg) or placebo, each over two weeks.
In this relatively non-anxious population (81% were mildly anxious or less, i.e. Beck Anxiety Inventory (BAI) scores ≤ 15), there was no significant difference between skullcap and placebo with BAI (p = 0.191). However, there was a significant group effect (p = 0.049), suggesting a carryover effect of skullcap. For Total Mood Disturbance measured by the Profile of Mood States, there was a highly significant (p = <0.001) decrease from pre-test scores with skullcap but not placebo (p = 0.072).
The limitations of carryover effect, generally low anxiety scores and differences in anxiety levels between groups at baseline (p = 0.022), may have reduced the chances of statistical significance in this study. However, as S. lateriflora significantly enhanced global mood without a reduction in energy or cognition, further study assessing its putative anxiolytic effects in notably anxious subjects with co-morbid depression is warranted.
By chance, all of the participants with moderate-to-severe baseline anxiety were in one group. In this group, there was a significant reduction in Beck Anxiety Inventory (BAI) scores compared with placebo.
American skullcap has been shown to be anxiolytic in humans as shown by a reduction in anxiety in healthy volunteers using the Beck Anxiety Inventory (BAI).
Evidence strength: Preliminary. Human evidence is limited to small crossover studies in primarily healthy, low-anxiety populations. Larger trials in clinically anxious populations are lacking.
5.2 Neuroprotection and Neurodegenerative Conditions
The review reveals the neuroprotective effects of Chinese Skullcap. Several studies have shown that baicalin and baicalein possess neuroprotective properties, which may be beneficial in neurodegenerative conditions like Alzheimer's and Parkinson's diseases.
Among the important flavones, baicalein is mainly found in the root of Scutellaria baicalensis Georgi. A number of studies have reported that baicalein has potent neuroprotective properties under in vitro as well as in vivo systems.
Evidence strength: Preclinical only. No well-controlled human trials currently establish clinical neuroprotection for neurodegenerative diseases. Evidence is restricted to cell-culture and animal models.
5.3 Anti-inflammatory Effects
A review identified over 50 species used in traditional medicine, and reported over 208 chemical constituents — including flavonoids, neo-clerodane diterpenoids, sesterterpenoids, and other terpenoids — characterised from 16 species and one variety. Pharmacological studies demonstrated a broad range of activities, including anti-inflammatory, antioxidant, antiviral, antibacterial, anticancer, hepatoprotective, neuroprotective, and cardiovascular and cerebrovascular effects.
Evidence strength: Primarily preclinical (cell and animal studies). Anti-inflammatory activity of isolated flavonoids such as baicalin and baicalein is well-documented at the mechanistic level in laboratory settings, but robust human clinical trial data specific to inflammatory conditions remain limited.
5.4 Antiviral Activity
One research group isolated 28 compounds from S. baicalensis and evaluated their anti-H1N1 viral, cytotoxic, and Nrf2 activation activities. The results indicated that free flavones were more potent than other types as anti-influenza, cytotoxic, and antioxidative compounds of S. baicalensis.
Evidence strength: Preclinical. Antiviral properties of skullcap flavonoids have been demonstrated in vitro and in some animal models, but clinical antiviral efficacy in humans has not been established through rigorous trials.
5.5 Cardiovascular Health
Previous studies have summarized the significant clinical potential of baicalin in the treatment of atherosclerosis, myocardial ischemia-reperfusion injury, hypertension, and heart failure through mechanisms including regulation of lipid metabolism, reduction of inflammation-induced damage, inhibition of oxidative stress, attenuation of apoptosis, and immune modulation. However, the specific signaling pathways involved have not been identified. In recent years, new findings have been published on the effects of baicalin on coagulation and fibrinolytic mechanisms, as well as on its toxicity.
Evidence strength: Primarily preclinical, with mechanistic review evidence. Large-scale human cardiovascular outcome trials are absent.
5.6 Antitumor Activity
Scutellaria baicalensis has demonstrated anti-tumor, anti-angiogenic, and anti-inflammatory properties. Baicalein, wogonin, and baicalin are the main pharmacologically bioactive compounds of S. baicalensis. The clinical trial of wogonin as an anti-cancer drug candidate has recently been approved by the State Drug Administration of China.
The antioxidant properties of the flavonoids found in Chinese Skullcap could contribute to its anti-cancer potential. By reducing oxidative stress and inflammation, the plant's extracts may help prevent or slow down the growth of cancer cells.
Evidence strength: Primarily preclinical (cell culture and animal studies). Clinical antitumor efficacy in humans has not been established for skullcap preparations as a whole. Wogonin has entered early-phase clinical investigation in China but results in humans are not yet conclusive.
5.7 Sedation and Sleep
Skullcap, particularly the species Scutellaria lateriflora, is a natural herb that has been traditionally used for its sedative properties, with historical applications in treating conditions like nervousness and insomnia. Indigenous Americans and European herbalists have utilized skullcap to alleviate symptoms associated with various nervous system disorders, including epilepsy. In recent years, scientific studies have begun to explore its therapeutic potential more extensively, revealing possible benefits for anxiety reduction and mood enhancement through mechanisms that may involve GABA stimulation.
Ten phytomedicines were identified as having preclinical investigations showing interaction with the GABA system, in addition to human clinical trials: kava, valerian, pennywort, hops, chamomile, Ginkgo biloba, passionflower, ashwagandha, skullcap, and lemon balm. Collectively, the literature reveals preclinical and clinical evidence for various phytomedicines modulating GABA-pathways, with comparative anxiolytic effect to the current array of pharmaceuticals, along with good safety and tolerability profiles.
Evidence strength: Traditional use is well documented; preclinical GABA-modulating evidence is strong. Direct human sleep-outcome trials for skullcap as a monotherapy remain limited.
6. Body Systems and Health Areas
Based on the totality of preclinical and available clinical evidence, skullcap species are associated with the following body systems and health areas:
- Central nervous system: Anxiolytic, sedative, and neuroprotective effects via GABAergic and serotonergic pathways; historical and limited human trial evidence for anxiety and mood.
- Cardiovascular system: Baicalin has been investigated for atherosclerosis, hypertension, myocardial protection, and coagulation modulation, primarily in preclinical studies.
- Gastrointestinal system: Traditional use in TCM for diarrhea, dysentery, hepatitis, and gastrointestinal inflammation; internally used in the treatment of enteritis, dysentery, diarrhea, and jaundice.
- Immune and infectious disease: Pharmacological studies have shown that extracts and compounds found in this genus have a wide range of biological activities, including anticancer, antioxidant, antiinflammatory, antiviral, antibacterial, cardioprotective, hepatoprotective, and neuroprotective properties.
- Female reproductive system: Native Americans used skullcap to promote menstruation, and a root extraction was often taken after childbirth to help heal the reproductive system.
- Oncology (investigational/preclinical): Apoptosis induction and cell cycle arrest observed in multiple cancer cell lines.
7. Dosage Forms and Reported Dosages
Typical doses (see individual product information): dried herb — 1 to 2 g three times per day; tea — 240 mL three times per day (pour 250 mL of boiling water over 5 to 10 mL of the dried herb and steep for 10 to 15 minutes); tincture — 2 to 4 mL three times per day.
In clinical research: In the Brock et al. placebo-controlled, double-blind, crossover study, 43 healthy participants were randomised to a sequence of three times daily S. lateriflora (350 mg) or placebo, each over two weeks.
Quantification in one phytochemical study identified baicalin in a 50% EtOH extract (40 mg/g) and its aglycone baicalein in a 95% EtOH extract (33 mg/g), as well as the amino acid GABA in H₂O and EtOH extracts (~1.6 mg/g) and glutamine in a H₂O extract (31 mg/g), as determined by HPLC.
More research is required to fully understand mechanisms of action, optimize therapeutic potential, and assess the safety profile of these preparations. There is, as yet, no universally established or pharmacopoeially standardized therapeutic dose applicable across all commercial products and species.
8. Safety Considerations and Drug Interactions
8.1 Hepatotoxicity
Skullcap (Scutellaria lateriflora) has been associated with cases of clinically apparent liver injury, but largely in association with other botanicals that have also been implicated in causing hepatotoxicity. Furthermore, in some instances phytochemical analysis has identified significant adulterants (germander) or mislabeling in cases of suspected skullcap hepatotoxicity.
Skullcap has been implicated in rare instances of clinically apparent liver injury, although in most cases multiple herbal medications were being taken and the role of skullcap in the hepatic damage was unclear. Furthermore, in some instances phytochemical analysis has identified significant adulterants (germander) or mislabeling in cases of suspected skullcap hepatotoxicity. In reported cases, the onset of symptoms and jaundice occurred within 1 to 12 weeks of starting skullcap, and the serum enzyme pattern was typically hepatocellular. Immunoallergic and autoimmune features were usually absent, although low titers of autoantibodies were not infrequent. Recovery was rapid once the herbal was discontinued, but some cases have resulted in acute liver failure.
Chinese skullcap is a different species, but may also have adverse effects on the liver. In one reported case, herbal hepatotoxicity from skullcap was identified as the most likely causative agent of liver injury based upon liver histology and re-challenge. This case highlights the importance of considering herbal supplement-induced hepatotoxicity in the differential of any patient who presents with acute hepatitis.
8.2 The Germander Adulteration Problem
Germander has been reported to be an adulterant of other herbal preparations including skullcap. Germander has been implicated in liver injury, even when used to brew herbal teas. Germander and other Teucrium extracts have many components including glycosides, flavonoids, saponins, volatile oils, and furan-containing neoclerodane diterpenoids, the last of which (Teucrin A and Teuchmaedryn A) are considered the hepatotoxins responsible for its liver injury. Because some cases historically attributed to skullcap hepatotoxicity likely involved germander contamination, accurate causality assessment for skullcap itself has been difficult.
8.3 Hypoglycemia Risk
Chinese skullcap has been documented as causing blood sugar levels to drop, raising the risk of hypoglycemia. This is particularly relevant for individuals using antidiabetic medications.
8.4 General Tolerability
While generally considered safe, some individuals may experience mild gastrointestinal discomfort.
8.5 Product Quality and Consistency
The concentration of active ingredients in skullcap can vary greatly between products and batches, leading to inconsistencies in their therapeutic effects and potential safety risks. It is important to choose quality products that clearly state the plant species (e.g., Scutellaria baicalensis or Scutellaria lateriflora) and avoid any blends containing unknown or untested additives.
8.6 Potential Drug Interactions
It is important to consider the potential side effects and interactions of Chinese Skullcap with other drugs or herbs. Given the documented GABAergic activity of skullcap flavonoids, additive CNS-depressant effects are mechanistically plausible when combined with other sedatives, anxiolytics, or hypnotics, though direct human pharmacokinetic drug-interaction studies are limited. The potential hypoglycemic effects of S. baicalensis suggest caution alongside antidiabetic agents.
9. Overall State of the Evidence
Skullcap — spanning primarily S. lateriflora and S. baicalensis — has a well-documented traditional history and a growing body of mechanistic (in vitro and animal) research supporting plausible biological activity across several domains. S. lateriflora significantly enhanced global mood without a reduction in energy or cognition in the most methodologically rigorous published human trial, but that trial was conducted in healthy volunteers rather than in clinically anxious populations, limiting generalisation. More research is required to fully understand its mechanisms of action, optimize its therapeutic potential, and assess its safety profile. The hepatotoxicity signal — while confounded by adulteration and multi-herb use — warrants attention, particularly for S. baicalensis-containing products used long-term.
References
Go back